{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:41:07Z","timestamp":1784194867484,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jinf.2016.04.031","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T09:46:59Z","timestamp":1462960019000},"page":"S115-S118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Systems immunology: Beyond antibody titers"],"prefix":"10.1016","volume":"72","author":[{"given":"Raquel","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2016.04.031_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.immuni.2010.10.011","article-title":"A decade of vaccines: integrating immunology and vaccinology for rational vaccine design","volume":"33","author":"D'Argenio","year":"2010","journal-title":"Immunity"},{"issue":"1645","key":"10.1016\/j.jinf.2016.04.031_bib2","doi-asserted-by":"crossref","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future. Philosophical transactions of the Royal Society of London Series B","volume":"369","author":"Greenwood","year":"2014","journal-title":"Biol Sci"},{"issue":"6","key":"10.1016\/j.jinf.2016.04.031_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"34","key":"10.1016\/j.jinf.2016.04.031_bib4","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.jinf.2016.04.031_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2014.00012","article-title":"Designing vaccines for the twenty-first century society","volume":"5","author":"Finco","year":"2014","journal-title":"Front Immunol"},{"issue":"24","key":"10.1016\/j.jinf.2016.04.031_bib6","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1001\/jama.2015.2427","article-title":"Broadly neutralizing antibodies and the development of vaccines","volume":"313","author":"Haynes","year":"2015","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.jinf.2016.04.031_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.jinf.2016.04.031_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virusres.2004.02.024","article-title":"Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?","volume":"103","author":"Beyer","year":"2004","journal-title":"Virus Res"},{"issue":"8","key":"10.1016\/j.jinf.2016.04.031_bib9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2016.04.031_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2016.04.031_bib11","doi-asserted-by":"crossref","first-page":"e1004869","DOI":"10.1371\/journal.ppat.1004869","article-title":"Host transcriptional response to influenza and other acute respiratory viral infections\u2013a prospective cohort study","volume":"11","author":"Zhai","year":"2015","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.jinf.2016.04.031_bib12","doi-asserted-by":"crossref","first-page":"e1001549","DOI":"10.1371\/journal.pmed.1001549","article-title":"Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection","volume":"10","author":"Mejias","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2016.04.031_bib13","doi-asserted-by":"crossref","first-page":"140033","DOI":"10.1038\/sdata.2014.33","article-title":"A comprehensive collection of systems biology data characterizing the host response to viral infection","volume":"1","author":"Aevermann","year":"2014","journal-title":"Sci Data"},{"issue":"3","key":"10.1016\/j.jinf.2016.04.031_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2009.07.006","article-title":"Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans","volume":"6","author":"Zaas","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jinf.2016.04.031_bib15","doi-asserted-by":"crossref","first-page":"e0120012","DOI":"10.1371\/journal.pone.0120012","article-title":"A novel host-proteome signature for distinguishing between acute bacterial and viral infections","volume":"10","author":"Oved","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.jinf.2016.04.031_bib16","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2006-02-002477","article-title":"Gene expression patterns in blood leukocytes discriminate patients with acute infections","volume":"109","author":"Ramilo","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jinf.2016.04.031_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2016.04.031_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2016.04.031_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/eji.201343657","article-title":"Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response","volume":"44","author":"Tan","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jinf.2016.04.031_bib20","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/srep02327","article-title":"High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature","volume":"3","author":"Henn","year":"2013","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jinf.2016.04.031_bib21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jinf.2016.04.031_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jiu079","article-title":"Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children","volume":"210","author":"Cao","year":"2014","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2016.04.031_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2014.04.007","article-title":"Ontogeny of early life immunity","volume":"35","author":"Dowling","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jinf.2016.04.031_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fimmu.2014.00434","article-title":"The role of environmental factors in modulating immune responses in early life","volume":"5","author":"MacGillivray","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2016.04.031_bib25","first-page":"115","article-title":"Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety","volume":"41","author":"Mastelic","year":"2013","journal-title":"Biol J Int Assoc Biol Stand"},{"issue":"2","key":"10.1016\/j.jinf.2016.04.031_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ni.2796","article-title":"Single-cell technologies for monitoring immune systems","volume":"15","author":"Chattopadhyay","year":"2014","journal-title":"Nat Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:51Z","timestamp":1759008231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":26,"alternative-id":["S0163445316300585"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.04.031","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systems immunology: Beyond antibody titers","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}